9th International mRNA Health Conference, 2021
The 9th International mRNA Health Conference was conducted as a hybrid event in Berlin and online on November 9 and 10, 2021. This year, the conference reached the highest number of participants since the first International mRNA Health Conference in Tübingen back in 2013. In total, more than 850 industry and academic professionals had registered. Around 300 participants travelled to Berlin to take part onsite, approximately 450 participants were part via the virtual conference platform.
40 outstanding scientists and representatives of future-oriented companies presented various aspects of mRNA technology in eight different sessions. They provided the opportunity to exchange and to learn more about the developments in this scientific field. In a keynote, Katalin Karikó highlighted the interesting history and development of mRNA technology.
The 9th International mRNA Health Conference was accompanied by a poster exhibition with almost 60 posters, accessible both onsite and virtually. For onsite participants, they were all lined up in a separate room giving the opportunity for long and intense exchanges at the poster sessions.
Our priority was to ensure the health and safety of every event participant. Therefore, the conference took place in accordance with the German 3G guideline (vaccinated, recovered, tested).
Photo credits: MIKA-fotografie | Berlin
9th International mRNA Health Conference
The 9th International mRNA Health Conference was conducted as a hybrid event in Berlin and online on November 9 and 10, 2021. This year, the conference reached the highest number of participants since the first International mRNA Health Conference in Tübingen back in 2013. In total, more than 850 industry and academic professionals had registered. Around 300 participants travelled to Berlin to take part onsite, approximately 450 participants were part via the virtual conference platform.
40 outstanding scientists and representatives of future-oriented companies presented various aspects of mRNA technology in eight different sessions. They provided the opportunity to exchange and to learn more about the developments in this scientific field. In a keynote, Katalin Karikó highlighted the interesting history and development of mRNA technology.
The 9th International mRNA Health Conference was accompanied by a poster exhibition with almost 60 posters, accessible both onsite and virtually. For onsite participants, they were all lined up in a separate room giving the opportunity for long and intense exchanges at the poster sessions.
Our priority was to ensure the health and safety of every event participant. Therefore, the conference took place in accordance with the German 3G guideline (vaccinated, recovered, tested).
Photo credits: MIKA-fotografie | Berlin
